Viewing StudyNCT04689347



Ignite Creation Date: 2024-05-06 @ 3:36 PM
Last Modification Date: 2024-10-26 @ 1:52 PM
Study NCT ID: NCT04689347
Status: UNKNOWN
Last Update Posted: 2022-04-04
First Post: 2020-12-22

Brief Title: 5FULV Irinotecan Temozolomide and Bevacizumab for MGMT Silenced Microsatellite Stable Metastatic Colorectal Cancer
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori Milano
Organization: Fondazione IRCCS Istituto Nazionale dei Tumori Milano

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-01-01
Start Date Type: ACTUAL
Primary Completion Date: 2022-12-31
Primary Completion Date Type: ESTIMATED
Completion Date: 2023-01
Completion Date Type: ESTIMATED
First Submit Date: 2020-12-22
First Submit QC Date: December 29 2020
Study First Post Date: 2020-12-30
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-04-01
Last Update Post Date: 2022-04-04
Last Update Post Date Type: ACTUAL